Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
A low-cost generic version of Truvada as PrEP will hit the market September 30.
Watch actress Selenis Leyva, TV host Michelle Visage and others promote the first State of HIV Stigma Study.
Plus: The Elizabeth Taylor AIDS Foundation and Gilead Sciences join the collective for a virtual town hall June 25.
FDA grants emergency use authorization, but randomized clinical trials of the antiviral drug show mixed results.
Hint: Gilead Sciences donated the meds for Trump’s HIV prevention program, so that cost isn’t the issue.
Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.
Bonus: Your donations to the Broadway Cares effort Emergency Grants for Pandemic Relief will be matched by Gilead Sciences.
Because many Latinx groups already receive grants from the drugmaker, they can apply for new funds during the coronavirus crisis.
As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.
Jevon Martin, CEO of Princess Janae Place, addresses the challenges facing trans people—including COVID-19.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
The U.S. Health Department launched “Ready, Set, PrEP” to provide the HIV prevention med at no cost.
This will provide free PrEP to as many as 200,000 uninsured Americans until 2030.
A look at the supply chain that results in very high costs for HIV and hepatitis C medications.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.